Federal procurement award details and spending trajectory for SUPERNUS PHARMACEUTICALS, INC. (SUPN)
Federal procurement award details and spending trajectory for SUPERNUS PHARMACEUTICALS, INC. (SUPN)
Cross-domain capital intelligence tracking records concurrent signal convergence for SUPERNUS PHARMACEUTICALS, INC. (ticker SUPN). Official federal procurement data reveals prime contract action obligations administered by the Federal Government valued at $50,000,000.00 registered on 2026-03-15. Concurrently, periodic transaction disclosures under the STOCK Act and institutional off-exchange volume indicate elevated market participation coinciding with legislative appropriations. When federal contract awards align with institutional accumulation and dark pool surge patterns, capital intelligence models flag SUPN as experiencing multi-stream alpha convergence, warranting rigorous quantitative scrutiny.
Verified Quantitative Data
| Metric | Value |
|---|---|
| Amount | $50.00M |
Full trading intelligence, federal contract history and congressional flow for SUPN.
Primary Source Record
This fact is compiled from public federal disclosure records. Explore the underlying dataset on the Federal Contract Explorer and the Capitol Trades leaderboard.
Data intelligence from public filings — not investment advice.